Table 3 Expected clinical outcomes per patient after treatment with Pregabalin or Gabapentin
Treatment | |||
|---|---|---|---|
Pregabalin (150–600 mg/d) | Gabapentin (2400 mg/d) | Difference (Pregabalin - Gabapentin) | |
Pain score | |||
Pre-treatment | 6.9 (0.0) | 6.9 (0,0) | 0.0 (0.0) |
Post-treatment | 4.1 (0.0) | 4.8 (0,0) | -0.6 (0.0) |
Days with | |||
No or mild pain | 36 (0.3) | 27 (0.3) | 9 (0.5) |
Moderate pain | 32 (0.3) | 38 (0.3) | -6 (0.5) |
Severe pain | 15 (0.2) | 19 (0.3) | -4 (0.3) |
Days with | |||
≥30% reduction in pain score | 50 (0.3) | 42 (0.4) | 8 (0.5) |
≥50% reduction in pain score | 36 (0.3) | 26 (0.4) | 10 (0.5) |
Quality-adjusted life-years (QALYs) | 0.1178 (0.0002) | 0.1115 (0.0002) | 0.0063 (0.0003) |